TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›CNXC

CNXC

Concentrix Corp

Next earnings Jun 29, 2026 (after close) · consensus $2.69 EPS, $2.52B rev

Last earnings +0.9% on 2026-06-29

Hold
$23.60
▼ -6.46%
$23.60▼ -52.69%
over 1Y
L $22.52H $59.81
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-6.5%
1W+4.8%
1M-17.2%
3M-12.3%
YTD-41.4%
1Y-52.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
D
Valuation
Fair value
Filings
Watch
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 11 analysts
Buy

Dirt-cheap cash machine (2.7x FCF) but a Webhelp impairment and AI disruption to CX outsourcing cap the upside.

Operating cash flow $807M · FY2025

Concentrix is a global CX/BPO outsourcer that, post-Webhelp, has scaled revenue to $9.83B but growth has stalled to +2.2% — a sharp deceleration from the double-digit, acquisition-fueled gains of FY2021–FY2024. The headline FY2025 net loss of -$1.28B (EPS -$20.36) looks catastrophic, but it is not a cash event: operating income was -$918M while operating cash flow actually rose 20.9% to $807M and gross profit held flat at $3.44B (35.0% gross margin). The loss is overwhelmingly a non-cash writedown — the company paid ~$3.77B for Webhelp in 2023 and the operating-income swing signals a large goodwill/intangible impairment marking that deal down. That is both reassuring (cash generation is intact) and damning (management/auditors are conceding Webhelp's value and growth won't materialize as underwritten). Retained earnings have flipped negative to -$177M.

On cash, the stock is extraordinarily cheap: at a $1.55B market cap the P/S is 0.2, and FCF (OCF $807M less capex $234M ≈ $573M) implies roughly 2.7x FCF — a ~37% FCF yield. Management is returning that cash, with $169M of buybacks (shares down 4.3%) and $89.6M of dividends, comfortably covered. For a deep-value investor this is the entire bull case.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 5:56 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$5.59B$6.32B$7.11B$9.62B$9.83B
Gross profit$1.97B$2.26B$2.58B$3.45B$3.44B
Operating income$572M$640M$661M$596M-$918M
Net income$406M$435M$314M$251M-$1.28B
Diluted EPS$7.70$8.28$5.70$3.71-$20.36
Net margin7.3%6.9%4.4%2.6%-13.0%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$5.75B
EV / EBITDA—
EV / Sales0.6
EV / FCF10.0
P / FCF2.5
PEG (trailing)—
Earnings yield-89.0%
FCF yield39.9%

Quality & risk

ROIC (est.)-9.8%
Free cash flow$572M
Total debt$4.64B
Net cash-$4.31B
Altman Z-Score0.82 distress
Piotroski F-Score4/9

Capital returns

Buyback yield11.7%
Dividend yield (est.)6.2%
Shareholder yield18.0%
Shares Δ YoY-4.3%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 10-Q Quarterly report2026-07-02
  2. 8-K Earnings results2026-06-29

    Q2 FY26 results released; investors gauging margin recovery after FY25 impairment

  3. 8-K Officer / director change2026-05-01

    Officer/director change disclosed (Item 5.02)

  4. 10-Q Quarterly report2026-04-03

    Q1 FY26: revenue roughly flat; heavy $4.6B debt, equity down 32% YoY

  5. 8-K Officer / director change2026-03-27

    Annual meeting vote results plus officer/director change disclosed

  6. 8-K Earnings results2026-03-24

    Q1 FY26 earnings release issued (Item 2.02)

  7. 8-K Material agreement2026-03-23

    Entered new financing agreement, adding a direct debt obligation

  8. 8-K Material agreement2026-02-24

    Entered material financing agreement creating new debt obligation

  9. DEF 14A Proxy statement2026-02-13

    2026 proxy: director slate, exec pay and say-on-pay for annual meeting

Recent filings

all on EDGAR ↗
10-QPeriod ending 2026-05-312026-07-02open ↗8-KPeriod ending 2026-06-292026-06-29open ↗SCHEDULE 13GFiling2026-05-14open ↗SCHEDULE 13GFiling2026-05-06open ↗8-KPeriod ending 2026-04-292026-05-01open ↗SCHEDULE 13D/AFiling2026-05-01open ↗4Period ending 2026-04-292026-05-01open ↗144Filing2026-04-29open ↗SCHEDULE 13G/AFiling2026-04-27open ↗4Period ending 2026-04-092026-04-09open ↗10-QPeriod ending 2026-02-282026-04-03open ↗4Period ending 2026-03-262026-03-30open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueA+
GrowthF
ProfitabilityF
Financial healthC-
MomentumF
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗Liabilities below 2× equity
22.4152-week59.81
Revenue
$9.83B
+2.2% YoY
Net margin
-13.0%
ROE
-46.6%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$9.83B+2.2%
Net income-$1.28B-609.1%
Gross profit$3.44B-0.4%
Operating income-$918M-254.0%
Diluted EPS-$20.36-648.8%
Cash & equivalents$327M+36.1%
Total assets$10.8B-10.3%
Total liabilities$8.02B+0.8%
Stockholders' equity$2.74B-32.1%
Gross: 35.0%Op.: -9.3%L/E: 2.92x

Frequently asked

Is Concentrix Corp (CNXC) a buy?
CNXC currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Dirt-cheap cash machine (2.7x FCF) but a Webhelp impairment and AI disruption to CX outsourcing cap the upside.
What is Concentrix Corp's quality score?
CNXC scores 43.783041017823706/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001803599, latest 10-Q filed 2026-07-02) · EODHD · Proprietary analysis · as of 6/30/2026, 9:56:15 AM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 1 open-market buy · 1 sale

2026-04-29
Groupe Bruxelles Lambert
10% owner
Sell6.00M @ $22.25$134M
2026-04-09
Valentine Andre S
Chief Financial Officer
Buy2.50K @ $27.95$69.9K
2026-03-26
Caldwell Christopher A
President and CEO
Buy1.00K @ $26.97$27.0K
2026-03-25
Council LaVerne H
Director
Award7.70K
2026-03-25
Cheng Chih-Kai
Director
Award7.70K
2026-03-25
OGUT BILGE
Director
Award7.70K
2026-03-25
Deason Jennifer
Director
Award7.70K
2026-03-25
Hayley Kathryn
Director
Award7.70K

Dividends

Quarterly
Yield (TTM)
7.5%
Annual / share
$1.77
Last ex-date
2026-07-24
Last amount
$0.36
ex 2026-07-24paid 2026-08-04$0.36
ex 2026-04-24paid 2026-05-05$0.36
ex 2026-01-30paid 2026-02-10$0.36
ex 2025-10-24paid 2025-11-04$0.36
ex 2025-07-25paid 2025-08-05$0.33
ex 2025-04-25paid 2025-05-06$0.33

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-06-29Miss -3.3% est▲ +0.92%8-K ↗
2026-03-24Miss -0.6% est▼ -19.85%8-K ↗
2026-01-13Miss -0.6% est▼ -3.21%8-K ↗
2025-09-25Miss -3.7% est▼ -1.10%8-K ↗
2025-06-26—▲ +1.77%8-K ↗
2025-03-26—▲ +1.11%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Why Concentrix (CNXC) Stock Is Up TodayBullish
finance.yahoo.com· 2026-07-01
Company News for July 1, 2026Bullish
finance.yahoo.com· 2026-07-01
S&P Futures Slip With Focus on U.S. ADP Jobs Report and Warsh’s RemarksBullish
finance.yahoo.com· 2026-07-01
3 Value Stocks We Find RiskyBullish
finance.yahoo.com· 2026-07-01
Concentrix (CNXC) Stock Still Looks Reasonable As Shares Fell 85%Bullish
finance.yahoo.com· 2026-07-01
Why Concentrix (CNXC) Is Down 7.9% After Trimming 2026 Outlook Amid Index ShiftBullish
finance.yahoo.com· 2026-07-01

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score44 vs 67
Revenue growth2.2% vs 7.5%
Net margin-13.0% vs 10.0%
Return on equity-46.6% vs 12.0%
P/E— vs 26.2

News sentiment

EODHD · 26d
Bearish
-0.17
vs typical · 71 articles
↓ cooling

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.